Compare OFG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OFG | BHC |
|---|---|---|
| Founded | 1964 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2012 | 1996 |
| Metric | OFG | BHC |
|---|---|---|
| Price | $51.52 | $6.31 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $56.75 | $7.50 |
| AVG Volume (30 Days) | 240.9K | ★ 1.7M |
| Earning Date | 10-21-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | 8.27 | ★ 423.08 |
| EPS | ★ 2.64 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $2.78 | $6.05 |
| Revenue Next Year | $1.66 | $0.48 |
| P/E Ratio | $19.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.71 | $4.33 |
| 52 Week High | $54.47 | $8.00 |
| Indicator | OFG | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 60.68 |
| Support Level | $51.46 | $6.14 |
| Resistance Level | $53.79 | $6.31 |
| Average True Range (ATR) | 0.94 | 0.24 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 83.07 | 90.07 |
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.